Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TYRA
Stock Latest News
Ratings
Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC
4d ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with a Peer Perform at Wolfe Research
11d ago
TYRA
Premium
The Fly
Tyra Biosciences reports Q1 EPS (64c), consensus (59c)
16d ago
TYRA
Premium
Ratings
Analyst Reiterates Buy on Tyra as Dabogratinib Catalysts Approach; $50 Price Target Maintained
16d ago
TYRA
Premium
Ratings
Buy Rating on Tyra Biosciences Backed by Dabogratinib’s Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
25d ago
TYRA
Premium
The Fly
Short Report: Lyft short interest at record high
1M ago
CAR
ARRY
Premium
Ratings
Dabogratinib’s Differentiated FGFR3 Profile and SURF302 Readout Position Tyra for Upside in Intermediate‑Risk NMIBC
1M ago
TYRA
Premium
Company Announcements
Tyra Bioscience Expands Board, Appoints New Independent Director
1M ago
8K
TYRA
Premium
Company Announcements
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch
1M ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with a Buy at Guggenheim
1M ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with a Buy at Guggenheim
2M ago
TYRA
Premium
The Fly
Canaccord starts Tyra Biosciences at Buy into 2026 data readouts
2M ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with a Buy at Canaccord
2M ago
TYRA
Premium
Company Announcements
Tyra Bioscience Strengthens Financial Leadership with New Officer
2M ago
8K
TYRA
Premium
The Fly
Tyra Biosciences price target raised to $56 from $42 at Piper Sandler
2M ago
TYRA
Premium
Company Announcements
Tyra Bioscience Raises $126 Million in Block Share Sale
3M ago
8K
TYRA
Premium
Ratings
Tyra Biosciences: FGFR3-Focused Pipeline and Upcoming Clinical Catalysts Support Buy Rating and Favorable Risk‑Reward
3M ago
TYRA
Premium
The Fly
Tyra Biosciences reports Q4 EPS (57c), consensus (53c)
3M ago
TYRA
Premium
The Fly
Short Report: Under Armour short interest at five-month lows
3M ago
UA
RDW
Premium
The Fly
Tyra Biosciences initiated with an Overweight at Cantor Fitzgerald
3M ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with an Overweight at Cantor Fitzgerald
3M ago
TYRA
Premium
The Fly
Tyra Biosciences price target raised to $45 from $30 at H.C. Wainwright
3M ago
TYRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
